SoftOx Solutions AS (OSL:SOFTX)

Norway flag Norway · Delayed Price · Currency is NOK
0.0562
-0.0022 (-3.77%)
At close: Mar 3, 2026
81.29%
Market Cap 136.87M
Revenue (ttm) 13.59M
Net Income (ttm) -3.00M
Shares Out 2.44B
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,069,960
Average Volume 13,385,634
Open 0.0600
Previous Close 0.0584
Day's Range 0.0562 - 0.0624
52-Week Range 0.0262 - 0.1745
Beta 2.21
RSI 41.88
Earnings Date Mar 25, 2026

About SoftOx Solutions AS

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norwa... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 2
Stock Exchange Oslo Børs
Ticker Symbol SOFTX
Full Company Profile

Financial Performance

In 2024, SoftOx Solutions AS's revenue was 7.91 million, an increase of 13.38% compared to the previous year's 6.98 million. Losses were -42.94 million, 8.86% more than in 2023.

Financial Statements

News

There is no news available yet.